Physiologic Response to the Pfizer-BioNTech COVID-19 Vaccine Measured Using Wearable Devices: Prospective Observational Study

Abstract

Background The Pfizer-BioNTech COVID-19 vaccine uses a novel messenger RNA technology to elicit a protective immune response. Short-term physiologic responses to the vaccine have not been studied using wearable devices. Objective We aim to characterize physiologic changes in response to COVID-19 vaccination in a small cohort of participants using a wearable device (WHOOP Strap 3.0). This is a proof of concept for using consumer-grade wearable devices to monitor response to COVID-19 vaccines. Methods In this prospective observational study, physiologic data from 19 internal medicine residents at a single institution that received both doses of the Pfizer-BioNTech COVID-19 vaccine was collected using the WHOOP Strap 3.0. The primary outcomes were percent change from baseline in heart rate variability (HRV), resting heart rate (RHR), and respiratory rate (RR). Secondary outcomes were percent change from baseline in total, rapid eye movement, and deep sleep. Exploratory outcomes included local and systemic reactogenicity following each dose and prophylactic analgesic use. Results In 19 individuals (mean age 28.8, SD 2.2 years; n=10, 53% female), HRV was decreased on day 1 following administration of the first vaccine dose (mean –13.44%, SD 13.62%) and second vaccine dose (mean –9.25%, SD 22.6%). RHR and RR showed no change from baseline after either vaccine dose. Sleep duration was increased up to 4 days post vaccination, after an initial decrease on day 1. Increased sleep duration prior to vaccination was associated with a greater change in HRV. Local and systemic reactogenicity was more severe after dose two. Conclusions This is the first observational study of the physiologic response to any of the novel COVID-19 vaccines as measured using wearable devices. Using this relatively small healthy cohort, we provide evidence that HRV decreases in response to both vaccine doses, with no significant changes in RHR or RR. Sleep duration initially decreased following each dose with a subsequent increase thereafter. Future studies with a larger sample size and comparison to other inflammatory and immune biomarkers such as antibody response will be needed to determine the true utility of this type of continuous wearable monitoring in regards to vaccine responses. Our data raises the possibility that increased sleep prior to vaccination may impact physiologic responses and may be a modifiable way to increase vaccine response. These results may inform future studies using wearables for monitoring vaccine responses. Trial Registration ClinicalTrials.gov NCT04304703; https://www.clinicaltrials.gov/ct2/show/NCT04304703

Metrics from Wearable Devices as Candidate Predictors of Antibody Response Following Vaccination against COVID-19: Data from the Second TemPredict Study

“…Importantly, rather than relying on participant-reported side effects, our study assessed objective (continuously assessed) physiological measures as predictors of vaccine responses. Data presented here speak to recent calls for examining wearable device data in tandem with immune responses to vaccines [12]. The continuous predictors in these analyses may have been more sensitive to the effects of vaccination in generating systemic inflammatory responses.…”

“…In this study, we tested whether a wearable device (Oura Ring), which collects data on dermal temperature, heart rate, heart rate variability, and various sleep metrics (total sleep duration, deep sleep duration, and rapid eye movement (REM) sleep duration) could be used to detect the early period of COVID-19 disease. Prior data suggest that wearable devices can detect changes in physiology that follow mRNA vaccination against COVID-19 [12]. Most participants received a COVID-19 vaccine during the study.…”

Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong

“…To date, no narcolepsy-related disorder case report is related to COVID-19 vaccination. There is a recent proof-of-concept study using wearable devices found an increased sleeping duration up to four days post-BNT162b2 vaccination [ 53 ]. The sleeping signal detected in this study encourages further investigation on the immunogenicity, mechanism and association between mRNA vaccine and sleeping disorders.…”

Smart Watches: Capturing Our Hearts

“…Wearable device data is increasingly used in large studies across several fields of medicine. Another example is the tracking of HRV, resting heart rate, and respiratory rate as a measurement of tolerance in patients after receiving the Pfizer-BioNTech COVID-19 vaccine [47].…”

“…By requiring standards of third-party validation of these devices in real-world settings, we can continue to allow data collected by smart watches to play an increasing role in our medical decision making, specifically related to the detection and monitoring of conditions, and trial designs [47,49]. Consumer-available devices present an ever-changing and exciting field of possibilities, especially in the cardiac patient [50].…”